Controlled release of peptide from biodegradable platforms for cardiovascular applications
Cenderitide, also known as CD-NP, is a designer peptide developed by Mayo Clinic for treating cardiovascular pathologies. CD-NP is synthesized by combining native mammalian c-type natriuretic peptide (CNP) and a C-terminus isolated from the dendroapis natriuretic peptide (DNP) of the venom of green...
Saved in:
Main Author: | Ng, Xu Wen |
---|---|
Other Authors: | Freddy Boey |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/55154 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Optimizing parameters for the controlled release of drugs from biodegradable nanoparticles
by: Teo, Sheng Yuan.
Published: (2010) -
In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents
by: Lao, Luciana Lisa
Published: (2010) -
Modeling of drug release from biodegradable triple-layered microparticles
by: Lee, Wei Li, et al.
Published: (2013) -
Gastric-floating microcapsules provide controlled and sustained release of multiple cardiovascular drugs
by: Lee, Wei Li, et al.
Published: (2013) -
In vitro-in vivo correlations of drug release for biodegradable polymer stent
by: Wang, Xin Tong
Published: (2010)